Osimertinib as neoadjuvant therapy in a patient with stage IIIA non-small cell lung cancer: a case report

Overview of attention for article published in Journal of Medical Case Reports, April 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 18,516 followers.

RT @jmedcasereports: Osimertinib as neoadjuvant therapy in a patient with stage IIIA non-small cell lung cancer https://t.co/bRdcS5kmjC ht…

Osimertinib as neoadjuvant therapy in a patient with stage IIIA non-small cell lung cancer https://t.co/bRdcS5kmjC https://t.co/8rojVlUTK6

RT @jmedcasereports: Osimertinib as neoadjuvant therapy in a patient with stage IIIA non-small cell lung cancer: a case report https://t.co…

Osimertinib as neoadjuvant therapy in a patient with stage IIIA non-small cell lung cancer: a case report https://t.co/g94b0xKeim

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.